{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:03:37Z","timestamp":1794035017349,"version":"4.8.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":204,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jocmr.2024.101066","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:47:20Z","timestamp":1722005240000},"page":"101066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduced response to regadenoson with increased weight: An artificial intelligence\u2013based quantitative myocardial perfusion study"],"prefix":"10.1016","volume":"26","author":[{"given":"Emmanouil","family":"Androulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Azzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Surkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Papagkikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranil","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Alpendurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocmr.2024.101066_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","article-title":"Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial","volume":"379","author":"Greenwood","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jocmr.2024.101066_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/eurheartj\/ehs022","volume":"34","author":"Schwitter","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jocmr.2024.101066_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002666","article-title":"Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis","volume":"8","author":"Takx","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib4","first-page":"1282","article-title":"The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping","volume":"141","author":"Knott","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jocmr.2024.101066_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12350-022-03066-6","article-title":"Strengths and weaknesses of alternative noninvasive imaging approaches for microvascular ischemia","volume":"30","author":"Leo","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jocmr.2024.101066_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jmri.20065","article-title":"Analysis of myocardial perfusion MRI","volume":"19","author":"Jerosch-Herold","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101066_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10554-021-02363-4","article-title":"Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: data from a multicentre prospective registry","volume":"38","author":"Monmeneu Menadas","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/ehjci\/jet278","article-title":"Safety and tolerability of regadenoson CMR","volume":"15","author":"Nguyen","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcmg.2008.02.003","article-title":"Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results","volume":"1","author":"Cerqueira","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib11","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2019190061","article-title":"Myocardial stress perfusion MRI using regadenoson: a weight-based approach in infants and young children","volume":"1","author":"Wilkinson","year":"2019","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1532-429X-14-89","article-title":"Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson","volume":"14","author":"Bhave","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101066_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12968-017-0355-5","article-title":"Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification","volume":"19","author":"Kellman","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101066_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12968-020-00682-4","article-title":"SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance","volume":"22","author":"Leiner","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2024.101066_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jocmr.2024.101066_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jcmg.2009.06.001","article-title":"Qualitative and quantitative scrutiny by regulatory process: is the truth subjective or objective?","volume":"2","author":"Dilsizian","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jcmg.2009.04.011","article-title":"Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial","volume":"2","author":"Mahmarian","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ehjci\/jeab193","article-title":"How to do quantitative myocardial perfusion cardiovascular magnetic resonance","volume":"23","author":"Sharrack","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ehjci\/jeaa252","article-title":"Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress","volume":"22","author":"Kotecha","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2024.101066_bib20","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10554-011-9949-4","article-title":"The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study","volume":"28","author":"DiBella","year":"2012","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664724010937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664724010937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:13:22Z","timestamp":1744416802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664724010937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S1097664724010937"],"URL":"https:\/\/doi.org\/10.1016\/j.jocmr.2024.101066","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced response to regadenoson with increased weight: An artificial intelligence\u2013based quantitative myocardial perfusion study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocmr.2024.101066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Cardiovascular Magnetic Resonance.","name":"copyright","label":"Copyright"}],"article-number":"101066"}}